New vaccine reduced Lyme disease cases by 70 percent in clinical trial
Pharmaceutical companies Pfizer and Valneva report that their Lyme disease vaccine LB6V reduced the number of disease cases by around 70 percent compared with placebo.
Pharmaceutical companies Pfizer and Valneva report that their Lyme disease vaccine LB6V reduced the number of disease cases by around 70 percent compared with placebo.